Feature Channels:

Vaccines

Add to Favorites Subscribe Share
Newswise: John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma

John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma

Hackensack Meridian Health

John Theurer Cancer Center at Hackensack University Medical Center is the only site in New Jersey and one of just 17 in the country participating in a multicenter international Phase II study of an innovative personalized cancer vaccine being evaluated in combination with pembrolizumab immunotherapy in patients with melanoma that has been surgically removed but has a high risk of coming back. The hope is that the vaccine can prime a patient's immune system to be more responsive to immunotherapy and reduce the risk of cancer recurrence.

Channels: Cancer, Clinical Trials, Immunology, Personalized Medicine, Vaccines, Surgery,

Released:
20-Feb-2020 10:55 AM EST
Newswise: Tulane University launches new coronavirus research program to develop a vaccine and advanced diagnostics

Tulane University launches new coronavirus research program to develop a vaccine and advanced diagnostics

Tulane University

From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.

Channels: Aging, Infectious Diseases, Public Health, Vaccines, Coronavirus,

Released:
20-Feb-2020 10:45 AM EST
Announcement
Newswise: Data scientists ID potential vulnerabilities in the COVID-19 virus

Data scientists ID potential vulnerabilities in the COVID-19 virus

UT Southwestern Medical Center

Data scientists analyzing genetic sequences of the COVID-19 coronavirus have identified potential vulnerabilities that could help in vaccine development and further study of the infectious disease now spreading worldwide.

Channels: All Journal News, Infectious Diseases, Public Health, Vaccines, Coronavirus,

Released:
17-Feb-2020 2:05 PM EST
Expert Pitch
Newswise: Alexander_web.jpg

FSU expert available to comment on effectiveness of flu vaccine

Florida State University

By: Bill Wellock | Published: February 14, 2020 | 3:35 pm | SHARE: As an outbreak of a new coronavirus makes headlines across the world, another more common infectious disease is spreading across the United States and beyond — the flu.About 8 percent of the U.S. population gets sick from the flu each season, according to the Centers for Disease Control and Prevention.

Channels: Infectious Diseases, Public Health, Vaccines, Coronavirus, Influenza,

Released:
17-Feb-2020 9:00 AM EST
Research Results
Newswise: Researchers Show How Ebola Virus Hijacks Host Lipids
  • Embargo expired:
    15-Feb-2020 7:00 AM EST

Researchers Show How Ebola Virus Hijacks Host Lipids

Biophysical Society

Robert Stahelin studies some of the world’s deadliest viruses. Filoviruses, including Ebola virus and Marburg virus, cause viral hemorrhagic fever with high fatality rates. Stahelin, professor at Purdue University, examines how these viruses take advantage of human host cells.

Channels: Medical Meetings, All Journal News, Infectious Diseases, Pharmaceuticals, Vaccines, Ebola, African News,

Released:
12-Feb-2020 12:30 PM EST
Expert Pitch

Young Men Unaware of Risks of HPV Infection and Need for HPV Vaccination

Rutgers University-New Brunswick

Young sexual minority men — including those who are gay, bisexual, queer or straight-identified men who have sex with men — do not fully understand their risk for human papillomavirus (HPV) due to a lack of information from health care providers, according to Rutgers researchers.

Channels: All Journal News, Healthcare, Infectious Diseases, LGBTQ Issues, Men's Health, Sex and Relationships, Vaccines, Grant Funded News, National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA),

Released:
11-Feb-2020 11:10 AM EST
Research Results
WoltersKluwer_CMYK-ol.jpg

Pneumococcal Vaccines Are Effective – But New Strategies Needed to Reduce Meningitis

Wolters Kluwer Health: Lippincott Williams and Wilkins

Pneumococcal conjugate vaccines (PCVs) have been highly effective in reducing pneumonia and other invasive infections caused by Streptococcus pneumoniae bacteria. But rates of meningitis have shown little change, as pneumococcal strains not targeted by PCVs emerge as more important causes of meningitis, reports a paper in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Channels: All Journal News, Infectious Diseases, Neuro, Vaccines,

Released:
7-Feb-2020 9:45 AM EST
Expert Pitch
Newswise: New Tool Monitors Real Time Mutations In Flu

New Tool Monitors Real Time Mutations In Flu

Rutgers University-New Brunswick

A Rutgers-led team has developed a tool to monitor influenza A virus mutations in real time, which could help virologists learn how to stop viruses from replicating. The gold nanoparticle-based probe measures viral RNA in live influenza A cells, according to a study in The Journal of Physical Chemistry C. It is the first time in virology that experts have used imaging tools with gold nanoparticles to monitor mutations in influenza, with unparalleled sensitivity.

Channels: All Journal News, Chemistry, Engineering, Infectious Diseases, Materials Science, Pharmaceuticals, Vaccines, Influenza,

Released:
6-Feb-2020 6:00 AM EST
Research Results


0.47328